For Authors

On this page: Submitting to the British Journal of Cancer | Before you submit | Publishing licenses | How to submit | What you can expect

Submitting to the British Journal of Cancer

BJC is proud of its editorial independence and strives to uphold the highest standards in every aspect of its decision-making and publishing process; we expect our authors to do the same. The guidance that follows is not and never could be exhaustive, but is intended to guide authors towards best practice.

What we publish

BJC welcomes the submission of high quality original and innovative research findings from all countries, if they add to understanding of the risk factors for and pathogenesis of cancer; further prevention and early detection; and contribute to improving the diagnosis, treatment and survival of patients.

  • Full-length papers should be no more than 5,000 words, reduced appropriately to allow for up to six figures or tables, and should be supported by key references.
  • Short communications of 1,500 words and up to three figures or tables are also published across the entire spectrum of cancer research.
  • Single case reports are very rarely accepted and only if they illustrate an important point of broad general interest.
  • Minireviews on current topics, some longer reviews and book reviews, are usually invited by the editor, but potential authors are encouraged to approach the journal with suggestions for these and other relevant articles.
  • Editorials and letters to the editor that relate to material that has been published in the journal are published at the Editor's discretion.
  • There are additional facilities for publishing supplementary material and online colour versions of figures that will be printed in black and white.
  • BJC authors may opt for open access publication, with a choice of licence types. This will be offered after papers are accepted.

Before you submit

Ethics

BJC does not accept work that is funded in any part by tobacco industry sources.

Typescripts that contain the results of human and/or animal studies will be accepted for publication only if it is made clear that a high standard of ethics was applied in carrying out the investigations.

Papers reporting clinical studies should contain a statement that they have been carried out with the approval of an appropriate ethical committee, which must be identified. The paper should include a statement that informed consent was obtained from patients, where this is appropriate.

Clinical trials should be registered, preferably prospectively, and the registration number, the registry name, and access details should be included in the paper.

Papers disregarding the welfare of experimental animals will be rejected. Authors may find Guidelines for the welfare and use of animals in cancer research, Workman et al, (2010), helpful in this regard. This paper was published in British Journal of Cancer 102 (11): 1555-1577. It is freely available to download from this website, under the terms of a Creative Commons Licence and should be cited appropriately.

Authorship

A paper is accepted for review by BJC on the understanding that:

  • it has not been and will not be submitted simultaneously to another journal, in whole or in part, in any language
  • it reports previously unpublished work
  • all named authors have seen the paper and have agreed to submit the paper to BJC in its present form
  • all those named as authors have made a sufficient contribution to the work to be considered as authors. BJC does not restrict the number of authors contributing to a paper, providing these conditions are met.
  • all authors have obtained any consents that may be necessary from their employers or funding bodies.
  • if the paper is accepted, all the authors will observe the terms of the Licence to Publish, and will seek the consent of the publisher acting for the owners of the journal, in any other circumstance.
  • if, during the time that a paper is being assessed by BJC, the authors intend to submit, do submit, or already have under consideration for publication, any related manuscript, they must declare this in their covering letter, or by a subsequent email addressed to the journal’s Main Editorial Office bjc@bjcancer.net.

A signed statement, that all named authors have read the manuscript, have agreed to the submission and have participated in the study to a sufficient extent to be named as authors, should accompany submitted manuscripts. This should accompany or form part of the covering letter.

If the authorship of a paper is changed in any way after it has been reviewed, the Editor will require a letter, signed by all authors named on the original or on the revised submission, explicitly agreeing to the change. Authors should ensure that all their names appear on the manuscript in the format that each author wishes to appear in print.

Plagiarism

BJC will investigate well-founded allegations of plagiarism (where an author can be shown to have passed off someone else’s work as their own without obtaining permission or giving references) or of double publication/self plagiarism (where an author reproduces their own published work without reference, as though it were new). BJC’s publisher, Springer Nature, is part of the CrossCheck initiative that helps editors to verify the originality of submitted manuscripts. BJC uses CrossCheck software to monitor manuscripts. Dubious manuscripts will be assessed, the authors challenged and the manuscript may be rejected immediately. In the case of published papers, if proven, the published record will be clearly amended with a reference to the plagiarised material highlighted.

Use of the English Language

Authors whose first language is not English are encouraged to consult a native English speaker working in a similar area for advice on the clear presentation of their manuscripts. Where this is not possible, they may wish to use a service such as that offered by Springer Nature Language Editing, but please note that the use of Springer Nature Language Editing will be at the author's own expense and in no way implies that the article will be selected for peer review or accepted by BJC (or any other journal). The decisions made by the editors of BJC are based on the quality and suitability of the work described in the manuscript.

The Editors of BJC reserve the right to make literary corrections to manuscripts.

Research support

Authors should include a paragraph at the end of their manuscripts, acknowledging the support they have received from all funding bodies and host institutions relevant to the work described. If required, grant numbers and clinical trial numbers may be included in this section. Authors are asked to check the accuracy and completeness of this information with care. Once the proofs have been approved, changes cannot be made and it may not be possible to publish corrigenda.

Conflict of Interest

BJC expects all the authors of a paper to declare, in the covering letter, any financial interest they may have related to the work described in their paper when they first submit the manuscript.

In addition, all authors should participate in preparing a short statement to appear at the end of their manuscript, describing any of their interests and involvements that have a bearing on the paper they are submitting. These can be broadly divided into:

  1. support for the work under consideration, or for other projects, either financial or in kind from any third party, company or organisation whose finances or reputation may be affected by the publication of the work
  2. any recent, existing or planned employment relationship or consultancy (whether paid or unpaid) any of the authors has with an organisation whose finances or reputation may be affected by the publication of the work
  3. any direct financial interest any of the authors or their spouses, parents or children has (personal shareholdings, consultancies, patents or patent applications) whose value could be affected by the publication

Authors who have no such interests, should also make a declaration to that effect in respect of this work and its publication

Authors may make a joint declaration that they have no such interests. But where such interests exist, each individual should be named and make their own declaration.

Permissions

Authors must obtain written permission to reproduce borrowed material (illustrations, tables and photographs). Authors must ensure that appropriate permission has been obtained for the publication of identifiable clinical photographs.

Borrowed and previously published illustrations should be acknowledged in the captions in this style: 'Reproduced by kind permission of . . . (publishers) . . . from . . . (reference).' It is the responsibility of the author to obtain all such permissions from the original publishers and authors, and to submit them with the manuscript.

Availability of materials and data

It is fundamental to the progress of science and improvement of the care and treatment of patients that others are able to make use of and build upon the work that is published in BJC. It is therefore understood that, by publishing a paper in BJC, authors agree that they will make reasonable efforts, wherever possible, to make available to colleagues in academic research any of the cells, nucleic acids, antibodies, reagents, protocols etc. used in the research reported and not available from commercial suppliers. If specific materials are to be distributed by a for-profit company, this should be stated in the paper.

If authors anticipate difficulties or restrictions in making material or information available, they should declare this in their covering letter.

In many areas of science and biomedicine, public repositories have been developed to facilitate the storage and distribution of scientific resources. BJC strongly encourages authors to make such deposits and to include the relevant access details and accession numbers in their manuscripts.

Guidelines and Systematic reviews

BJC has compiled a Checklist for Guidelines for authors of papers that contain guidelines for clinical practice. Authors of relevant papers are asked to consult them before submitting to BJC and to address any comments they may have in their covering letter.

BJC is broadly supportive of initiatives to improve the quality of reporting of medical research such as REMARK, PRISMA and encourages authors, where appropriate, to follow them and cite references to them in their papers.

Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009) Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 6(7): e1000097. doi:10.1371/journal.pmed.1000097

McSane LM et al (2005) REporting recommendations for tumour MARKer prognostic studies (REMARK). British Journal of Cancer 93, 387-391. Doi:10.1038/sj.bjc.6602678

Referee recommendation

Authors may make up to six suggestions, in their covering letter and in their online submission, for suitable referees for their manuscript (please provide names, institution and email address). Authors may also ask that certain individuals are not approached. Recommended referees should have no close links to any of the authors, for example they should not have worked or published together within the last two years. BJC undertakes to consider carefully any recommended exclusions, but makes no commitment to follow reviewer recommendations.

Communication with the media and embargo

Manuscripts submitted to BJC should not be discussed with the media before they are accepted for publication. BJC may halt the consideration of a paper if this condition is not observed. Once a paper is accepted, authors are required to observe BJC's embargo and to work with the BJC's press team, notifying the BJC's Main Editorial Office immediately of any press interest in their paper.

Publishing licences

Quick links
If you already
know which licence you need, please download it here
arrow
BJC Standard Licence Creative Commons Licence Creative Commons Licence

BJC Licence choices

All BJC authors retain their copyright under our licence terms. CRUK own the title and hold the copyright in the journal as a whole.

BJC offers authors a choice of three publishing licences, each of which has many benefits for authors.

Authors are asked to be mindful of the requirements of their employers and research funders when selecting a licence, as BJC cannot easily change the licence terms once papers are published.

BJC Standard Licence Licence to Publish – BJC Standard Version
Download this licence Under this licence
  • authors retain the rights to reuse material taken from their papers in their own future publications and for teaching purposes within their own institutions
  • authors may post the final accepted manuscript to their employers/funders website for release six months after publication in BJC (Green Open Access compliance)
  • authors are required to transfer to Cancer Research UK (CRUK), the owners of BJC, only those rights that are needed by its licencee, Springer Nature, to publish, distribute and promote the paper and BJC to maximum effect
  • BJC papers are made available to millions of readers around the world who are covered by Springer Nature site licences
  • papers published under this licence are made freely available to all readers under a CC/BY-NC-SA/4.0 licence one year after publication in BJC
  • this licence is free of charge

BJC’s Open Access licences both make papers, in their final published form, freely available to academic colleagues immediately they are published, but allow authors either:

  • to choose to make their papers freely available to readers
  • but to have their work to be attributed whenever it is quoted or reused with a requirement that all subsequent and further uses will be on the same basis and will also require attribution (share alike)
  • and to have the publisher to continue to protect and promote distribution of their papers, meaning that others will not be able to use it for commercial purposes without permission 
Creative Commons Licence Creative Commons
Attribution - Non-commercial - Share alike
Download this licence This licence
  • allows readers to copy, distribute and transmit the paper for any legal purpose
  • others may alter, transform add to or build upon the original paper, but any such reuse or distribution must carry a clear attribution to the original author, usually including the DOI, and must require others to use a similar licence (share alike)
  • does not allow commercial reuse without further permission from the publisher who will continue to protect commercial distribution of the paper
  • a fee is payable for this licence
  • authors choosing this licence will not pay additional charges for publishing colour figures
  • further details on this licence are available at: http://creativecommons.org/licenses/by-nc-sa/4.0

or:

  • to make their paper freely available without limits, including allowing commercial reuse, provided that the work is attributed when first reused.
Creative Commons Licence Creative Commons
Attribution
Download this licence This licence
  • allows readers to copy, distribute and transmit the paper for any legal purpose
  • others may alter, transform add to or build upon the original paper as they choose
  • the initial such reuse must carry a clear attribution to the original author, usually via the DOI, but thereafter this is not required for subsequent reuse
  • allows commercial reuse for any legal purpose without further permission
  • a fee is payable for this licence
  • authors choosing this licence will not pay additional charges for publishing colour figures
  • further details on this licence are available at: http://creativecommons.org/licenses/by/4.0/

BJC OPEN articles will be identified online and in print by the BJC OPEN logo and the appropriate Creative Commons logo.

BJC encourages the deposit of final accepted manuscripts in repositories such as PubMed Central.

Twelve months after publication in an issue of BJC, all content is made freely available to readers via PubMed Central and the BJC website (www.bjcancer.com) under the terms of BJC’s attribution, non commercial, share alike licence (CC BY NC SA), with the exception of those papers first published under BJC’s attribution only licence (CC BY), which retain it.

All authors may post a copy of the final accepted manuscript to their own website, to their employer's website or to that of the funder of the work described, provided that authors cite the publication reference and DOI number on any deposited version, and provide a link from the final accepted manuscript to the published article on the BJC website.

If an Open Access option is chosen, the final accepted manuscripts can be made available on publication, if it is required but should be clearly linked to the final published version which will be freely available at www.bjcancer.com

If the standard licence is chosen, the the final accepted manuscript can be made freely available six months after the date of publication of the print issue in which the paper appears, ("Green" Open Access Compliance).

Authors are encouraged to opt into Springer Nature’s Manuscript Deposition Service, which means that 6 months after publication, Springer Nature will deposit the author’s accepted manuscript in pubmedcentral on behalf of the author. This choice must be made during the online submission process and the relevant information concerning the funding bodies for all authors must be provided at that stage. Authors who do not choose this service are still able to deposit the accepted version of their manuscript themselves, in any repository of their choice, 6 months after publication.

Authors may, if they wish, declare which licence they intend to choose when papers are submitted, but this choice will not affect the journal’s editorial process. After a manuscript is accepted all authors will be asked to download and sign the BJC Publishing Licence of their choice.

Summary of Time-lines for BJC Licences and Open Access

 

BJC Licence Choices BJC Standard Licence BJC OPEN ACCESS
CC-BY-NC-SA
Creative Commons Licence
BJC OPEN ACCESS
CC-BY
Creative Commons Licence
Manuscript is Accepted Authors may self-archive the final accepted manuscript on their own, their Employer’s or their Funder’s website and make it freely available six months after it is published in an issue of BJC – using this licence

Creative Commons Licence
Authors may self-archive the final accepted manuscript on their own, their Employer’s or their Funder’s website and make it freely available imediately it is published in an issue of BJC – using this licence

Creative Commons Licence
Authors may self-archive the final accepted manuscript on their own, their Employer’s or their Funder’s website and make it freely available imediately it is published in an issue of BJC – using this licence

Creative Commons Licence
Advance Online Publication & publication in an issue of BJC Content available to readers with a licence or subscription to BJC Open Access

Creative Commons Licence
Open Access

Creative Commons Licence
One year after publication in an issue of BJC. All papers are available with an OPEN ACCESS Licence Open Access

Creative Commons Licence
Open Access

Creative Commons Licence
Open Access

Creative Commons Licence

Cost of Open Access in BJC

BJC authors who choose a BJC OPEN licence will not pay any additional charges for publishing colour figures.

BJC authors based at an institution with an active site licence to BJC pay a reduced article processing charge for publishing open access in BJC.

BJC OPEN prices for CC-BY-NC-SA Licence:

Creative Commons Licence

 

 

Authors at an institute with no site licence
Sterling (£) US dollars ($) Euros (€)
2,300 3,540 2,810
Authors at an institute with a site licence
Sterling (£) US dollars ($) Euros (€)
1,700 2,620 2,070

(plus VAT or local tax where applicable)

BJC OPEN prices for CC-BY Licence: 


Creative Commons Licence

 

 

Authors at an institute with no site licence
Sterling (£) US dollars ($) Euros (€)
2,750 4,250 3,350
Authors at an institute with a site licence
Sterling (£) US dollars ($) Euros (€)
2,000 3,100 2,450

(plus VAT or local tax where applicable)

Visit Springer Nature's open access funding page for information about research funders and institutions that provide funding for open access.

Springer Nature also offers an APC support service to make it easier for Springer Nature authors to discover and apply for open access funding. For advice on what funding is available to you and help in approaching funders and institutions, please contact us at openaccess@nature.com.

Government employees from USA, UK and Canada are asked to contact the BJC Main Editorial Office (bjc@bjcancer.net), as they will need to sign an appropriate Government Employee Licence to Publish form. Authors whose Employer‘s have other specific licencing requirements should also contact the BJC Main Editorial Office to discuss these requirements.

Authors who have not chosen an Open Access licence and require a PDF of their paper for an academic purpose (for example, inclusion in a PhD Thesis), should also contact the Editorial Office (bjc@bjcancer.net).

Please follow these instructions carefully to ensure your paper is processed promptly.

For further information about BJC OPEN, please see the BJC OPEN FAQs.

How to submit

Manuscripts should be submitted via our Online Submission site

You can also contact them at

BJC Main Editorial Office

First floor Angel Building
407 St John Street
London EC1V 4AD
UK
Tel: +44 (0)20 3469 6179
Fax: +44 (0)20 3070 0638

Covering letter

All submissions should be accompanied by a covering letter setting the new paper in context. You will find a template for such a letter here

Manuscript format

Manuscripts, which must be written in English, should be typed using double spacing with a wide margin all round the text. Manuscripts must be concise, overly long manuscripts may be rejected on that basis. Authors are encouraged to make use of online only Supplementary Material when additional data is needed to support their conclusions. All Supplementary Material must be shown to the referees and should be submitted with the paper.

  • Full papers must not exceed 5000 words, which should include all figure legends and associated text. They should contain no more than six display items: figures and/or tables. Figures should be as concise as possible and should be prepared with regard for the current design of the BJC page and our Guide to Preparing Artwork. Figures must not have more than eight constituent parts and they must not exceed one page including their figure legend. If tables are likely to occupy more than one page when typeset in BJC’s current style, following the examples given in our Table Style Guide, the total number of display items submitted should be reduced accordingly. Full papers should be divided into sections: a structured abstract of about 200 words; introduction; materials and methods; results; discussion; acknowledgements; and should be supported by key references.
  • Short communications should comprise approximately 1500 words and up to three figures or tables, prepared as described above. They should be supported by a shortened list of references and should have the section headings; introduction; materials and methods; results; discussion; acknowledgements and a shorter structured abstract of approximately 100-150 words.
  • Minireviews should have 3000-3500 words, with appropriate reductions for one or two figures or tables, and should include a brief abstract, an introduction, a conclusion, and no more than 30 references.
    Minireview figures are usually restyled, please discuss this with the Main Editorial Office when manuscripts are accepted.
    All minireview articles will have their figures published with a facility for all readers to download free PowerPoint slides via the BJC website.

Title page

Your title page, numbered as 1, should give the title in bold letters (not normally exceeding 100 characters), a running title (not to exceed 50 characters) and all the authors' names in the preferred format (exactly as they are to appear in the published version), with affiliations and complete addresses, including postal (zip) codes.

Please indicate clearly who the corresponding author is. Both an e-mail address and a full postal address are required for the corresponding author.

When preparing the final manuscript, corresponding authors are asked to recheck and update

  • the order in which names are to appear
  • the exact format and spelling of all names
  • the addresses of all authors, ensuring that addresses are complete and properly identify the institutions where authors are working.

It will not be possible to correct avoidable omissions and mistakes once they are published.

Structured abstracts and keywords

You should prepare an abstract of your manuscript, of a maximum of 200 words summarising its content (reduced to a maximum of 150 words for a short communication).

BJC requires structured abstracts for research papers and short communications. Please use these headings for your abstract: Background, Methods, Results, and Conclusion or Interpretation, following the structure of your paper as closely as is possible.

BJC uses unstructured abstracts for minireviews, reviews and similar papers. Letters and editorials do not need abstracts.

Please type your abstract on a separate sheet following the title page.

At least three and no more than twelve keywords, should be listed after the abstract.

During the submission process, you will be required to choose the most relevant and specific subject terms that apply to your manuscript from our Subject Ontology, this will ensure that your article will be more discoverable and that it will appear on appropriate subject specific pages on nature.com, in addition to the journal’s own pages. Your article should be indexed with at least two and no more than five unique subject terms that describe the key subjects and concepts in your manuscript.

Click here for help with allocating Ontology terms.

Units & abbreviations

Please avoid abbreviations in the title and abstract. All unusual abbreviations should be fully explained at their first occurrence in the text.

All measurements should be expressed in SI units. For more detailed recommendations, authors may consult Baron DN & H McKenzie-Clark (eds) (2008) Units, Symbols and Abbreviations: A Guide for Authors and Editors in Medicine and Related Sciences (Sixth Edition).

Drug names

Generic drug names should be used.

Reference Style

BJC papers are referenced using a modified Harvard referencing style. Please see below for examples:

Only papers closely related to the author's work should be quoted, and these should wherever possible be original papers rather than reviews. Exhaustive lists should be avoided. Citation of conference proceedings or meeting abstracts should also be avoided unless there is no other reference.

References in the text should be made by giving, in brackets, the author's surname, with the year of publication.

When the reference is to a specific part of a book, the page number should also be cited. When reference is made to a work by three or more authors, the first name followed by et al, should be used for all citations in the text (Weiss et al, 2001). If several papers by the same first author and from the same year are cited, a, b, c, etc, should be added after the year of publication. Authors are asked to check the accuracy of all references before submitting a manuscript. References should be brought together at the end of the paper in alphabetical order, where titles of papers and all authors' names should be given in full.

Names of journals should be abbreviated as in Index Medicus, followed by the volume number and the initial and final page numbers, e.g.:

Nagai H, Pineau P, Tiollais P, Buendia MA, Dejean A (1997) Comprehensive allelotyping of hepatocellular carcinoma. Oncogene 14: 2927 - 2933

Wherever possible, include the digital object identifier (DOI), from the article's title page. Please note the following example:

Nanduri and Zimniak P (1999) Arch Biochem Biophys 362: 167 - 174, doi:10.1054/abbi.1998.1009

References to books and monographs should appear as in the following examples:

Means JH (1984) The Thyroid and its Diseases. Lippincott: Philadelphia

Stevenson AC (1966) Sex chromatin and sex ratio in man. In Sex Chromatin, Moore A. (ed) pp 405 - 425. W. B. Saunders: Philadelphia

Figures

Figures and images should be labelled sequentially, numbered and cited in the text. Figure legends should be printed, double spaced, on a separate sheet titled 'Titles and legends to figures'. Figures should be referred to specifically in the text of the paper but should not be embedded within the text. The use of three-dimensional and shadowed histograms is strongly discouraged when the addition of the third dimension gives no extra information. If a table or figure has been published before, the authors must obtain written permission to reproduce the material in both print and electronic formats from the copyright owner and submit it with the manuscript. This follows for quotes, illustrations and other materials taken from previously published works not in the public domain. The original source should be cited in the figure caption or table footnote.

Artwork Guidelines

A detailed guide to preparing artwork for submission can be downloaded at http://www.nature.com/aj/artworkguidelines.pdf. Please submit production quality artwork with your initial online submission. Individual figures may be submitted in any one of the BJC’s preferred formats, ideally TIFF or EPS files.

If your paper is accepted for publication and you have already submitted production quality artwork, following the Guide to Preparing Artwork, it will not be necessary to resubmit the artwork following the peer-review process, except where changes are required by the reviewers or our Editor.

Colour in print

Full colour illustrations may be included in the printed text, at the discretion of the editor.

A charge will normally be made to the author to cover the extra costs incurred in originating and printing colour illustrations. BJC has a standarised scale of charges for the first three colour figures with no further charges being made for additional colour. It is helpful if authors who submit colour figures indicate in their covering letter that they are willing, in principle, to meet these costs. Prior to publication, authors will be advised of the costs and asked to make arrangements to pay them.

Authors who choose a BJC OPEN licence do not pay additional charges for colour figures.

Colour online

We are usually able to substitute colour versions of illustrations in the HTML version of the online journal at no additional cost. The online PDF of the paper exactly matches the printed journal and will therefore carry the black and white version of the figure, as printed. Authors wishing to take advantage of this facility are asked to submit a 300 dpi black and white and a colour file for the electronically published version. Please refer to the Guide to Preparing Artwork.

Tables

Tables should only be used to present essential data. Each must be on a separate sheet with a title or caption and be clearly labelled, sequentially. Please make sure each table is cited within the text and in the correct order, e.g. (Table 3).

Tables should ideally be presented in Excel, one table per workbook. It is imperative that the tables are editable. Please save the files with extensions .xls / .xlsx / .ods / or .doc or .docx. Please ensure that you provide a 'flat' file, with single values in each cell with no macros or links to other workbooks or worksheets and no calculations or functions.

BJC has recently changed its style for tables. Please consult our Guide to Preparing Tables, for examples, and follow it as closely as possible.

Supplementary online material

Authors wishing to provide additional material supporting their paper, may wish to have this published online as supplementary material linked to the paper on the BJC website.

All supplementary materials must be submitted with the original manuscript and will be shown to referees. This allows papers to have greater depth, online enhancements, such as video clips and additional data sets, making them more useful to fellow specialists in the field who require detail, without distracting more general readers.

Authors should ensure that supplementary information is supplied in its FINAL format because it is not subedited and will appear online exactly as submitted. It cannot be altered, nor can new supplementary information be added, after the paper has been accepted for publication. All supplementary material must be cited in the text of the manuscript, sequentially.

For further information regarding acceptable file formats, please refer to the Guide to Preparing Artwork

What you can expect

Efficient, fast review and publication

Authors who choose to publish in BJC can be assured that its own editorial team and the staff at Springer Nature are committed to maintaining the highest possible quality and standards at all stages of review and then in processing accepted papers for publication.

BJC uses a web-based system for handling submitted papers during the review stages and is committed to reducing the time it takes to reach a decision about a manuscript as far as is consistent with good decision making. All submissions (provided there are no overriding problems of format) are assessed by BJC's specialist editors. Those papers that are judged unlikely to meet BJC's acceptance criteria are returned promptly, so that their authors may submit them elsewhere.

Proofs

When the proofs are ready to be downloaded, an email is sent to the corresponding author containing a URL link. Once downloaded proofs, can be annotated in Adobe Reader (8.0 or higher) or Adobe Acrobat. Corrected proofs should be returned via e-mail to bjcproofcorrections@nature.com. Proofs should be returned within 48 hours of receipt. Failure to do so may result in a delay to publication. Extensive alterations to the manuscript cannot be made at this stage, only errors may be corrected in the proof.

Offprints

Offprints may be ordered on a form that will accompany your proof notifications and should be returned along with the proofs to the above e-mail address. Credit card details may be entered on the form (if required) and faxed securely to +44(0)1256 810972

Online publication

Most papers published in BJC are released online individually, at least two weeks before they appear in an online issue of the journal. Online issue publication coincides with the mailing of the printed issue. The online version of the paper is identical to the printed version and can be referenced by its DOI (see below). When the online issue is published, full referencing details become available. BJC does not publish preliminary, unedited versions, thus maintaining BJC's tradition of excellence and also the integrity of the published record.

Digital Object Identifier

A unique digital object identifier (DOI) is assigned to every article BJC publishes.

The DOI initiative is an internationally agreed system for identifying electronic content and is guided by the International DOI Foundation, composed primarily of academic publishers and societies. The DOI appears on the title page of the article. It is assigned after the article has been accepted for publication and persists throughout the lifetime of the article. It is important to include the article's DOI in the reference as volume and page information is not always available for articles published online. The DOI should be cited in a reference following this style.

Clayton, JD, Kyriacou, CP, Reppart SM (2000) Keeping time with the human genome. Nature 409: 829 - 831, doi:10.1038/35057062

Where a paper has not yet appeared in a Volume/Issue of a journal, it should be cited following the style:

Yoo M-J, Szadkowski E, Wendel JF (2012). Homoeologexpression bias and expression level dominance inallopolyploid cotton. Heredity (e-pub ahead of print, 21 November 2012; doi:10.1038/hdy.2012.94).

Exposure - widest possible readership

BJC, and other Springer Nature journals are available online via site licenses to academic, corporate and government institutions and consortia around the world. BJC is available to members of these institutions at the click of a mouse, adding speed and visibility to authors' research papers. Please see the BJC Subscriptions page for further information.

Regular free e-mail alerts

Springer Nature now reaches half a million scientists and researchers in many disciplines, via e-alerts sent when new issues go live on journal websites. E-alerts are sent to all who have signed up to receive them and for BJC, there are currently 86,000 ensuring extensive worldwide exposure for BJC authors.

E-alert recipients can click through to the full article if they are subscribers or they work at an institution with a site licence, otherwise they can click through to the article's abstract and have the option to purchase a copy.

If you would like to sign up for BJC’s Table of Contents Alerts, please follow this link.

Abstracting and indexing

BJC is included in the leading abstracting and indexing services including ISI, MEDLINE, EMBASE and BIOSIS. Extensive reference linking to MEDLINE, ISI, Chemport and others via services such as Crossref and DOI numbers provide seamless online linking between articles and databases.

Media coverage

BJC features several of the papers and reviews from each of its issues on its own website, thus increasing their exposure. Cancer Research UK issues press releases about BJC articles, from time to time. Authors who wish to feature their work in local media are asked to contact the Main Editorial Office.

Extending science further - global collaborations

BJC has enthusiastically joined Springer Nature in supporting projects aimed at making current research available to a broader community of scientists and practitioners.

The HINARI project

BJC (and all Springer Nature journals) are in WHO's HINARI (Health InterNetwork Access to Research Initiative) scheme which provides free access to public institutions in developing countries. For further information, please visit the HINARI project website.